Atlas Trials

Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain

Clinical trial NCT03281200 · COMPLETED

Trial details

NCT number
NCT03281200
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Idiopathic Pulmonary Fibrosis
Start date
2017-10-24
Primary completion
2018-06-07
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.